Who makes Lipitor generic?
One generic, curiously enough, is being manufactured by Pfizer, the company that makes Lipitor, but it will be distributed by New Jersey-based Watson Pharmaceuticals. The other generic, approved yesterday by the FDA, is from India-based Ranbaxy Laboratories.
What company sells Lipitor?
Viatris, the maker of LIPITOR, is proud to offer the brand-name cholesterol medication that has been prescribed to over 29 million patients.
What are the generic forms of Lipitor?
Lipitor’s generic name is atorvastatin. Two generic drugmakers, Ranbaxy and Watson, can start selling generic atorvastatin in the U.S. right away.
When did Ranbaxy start selling generic Lipitor in the US?
In June 2008, Ranbaxy settled the patent dispute with Pfizer, allowing them to sell Atorvastatin Calcium, the generic version of Lipitor and Atorvastatin Calcium-Amylodipine Besylate, the generic version of Pfizer’s Caduet, in the US, starting on 30 November 2011.
How much does Ranbaxy Laboratories make in a year?
In December 2005, Ranbaxy’s share price was hit by a patent ruling disallowing production of its own version of Pfizer ‘s cholesterol -cutting drug Lipitor, which has annual sales of more than $10 billion.
Who are the major manufacturers of Lipitor generics?
Branded drug: Lipitor. U.S. sales: $2.23 billion. Companies: Daiichi Sankyo/Ranbaxy Laboratories, $1.20 billion; Watson Pharmaceuticals, $1.02 billion. Perhaps the biggest generics news of the last 12 months–arguably of the last 12 years–was the fall to generics of Pfizer’s ($PFE) cholesterol-lowering drug Lipitor, the undisputed King of Drugs.
When did Sun Pharmaceutical buy out Ranbaxy Laboratories?
On 7 April 2014, India-based Sun Pharmaceutical and Japan-based Daiichi Sankyo jointly announced the sale of the entire 63.4% share of Ranbaxy from Daiichi Sankyo to Sun Pharmaceutical in a $4 billion all-share deal. Under these agreements, shareholders of Ranbaxy were to receive a 0.8 share of Sun Pharmaceutical for each share of Ranbaxy.